Literature DB >> 27145263

Prophylactic treatment with plasma-derived C1 inhibitor in idiopathic non-histaminergic angioedema.

Carmela Gravante1, Laura Carucci1, Maria Bova2, Angelica Petraroli1, Arturo Genovese1, Gianni Marone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27145263     DOI： 10.1111/pai.12592

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  3 in total

1.  Angioedema suppressed by a combination of anti-histamine and leukotriene modifier.

Authors:  Brendan N Wong; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2017-06-13       Impact factor: 3.406

2.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

3.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.